![]() |
市場調查報告書
商品編碼
1898024
真空輔助乳房切片設備市場規模、佔有率及成長分析(按產品、類型、技術、應用、最終用戶和地區分類)-2026-2033年產業預測Vacuum-Assisted Breast Biopsy Device Market Size, Share, and Growth Analysis, By Product (Core Needle Biopsy Devices, Vacuum-assisted Biopsy Devices), By Type, By Technique, By Applications, By End User, By Region - Industry Forecast 2026-2033 |
||||||
全球真空輔助乳房切片設備市場規模預計在 2024 年達到 9.0684 億美元,從 2025 年的 10.1294 億美元成長到 2033 年的 24.5475 億美元,在預測期(2026-2033 年)內複合年成長率為 11.7%。
受乳癌發生率不斷上升的推動,真空輔助乳房切片裝置(VABB)市場正經歷顯著成長。乳癌是全球女性面臨的主要健康問題之一。與傳統診斷方法相比,VABB具有更快的周轉時間和更高的便利性。它只需一次穿刺即可採集足夠的組織樣本,從而能夠獲得多個檢體,有助於提高診斷的準確性。這降低了漏診或組織學診斷不足的風險。由於乳癌是女性死亡的主要原因之一,公眾意識的提高以及政府主導的早期檢測措施預計將進一步推動對VABB的需求。這將鞏固VABB作為現代乳癌診斷首選設備的地位。
全球真空輔助乳房切片設備市場促進因素
與傳統切片檢查技術相比,真空輔助乳房切片裝置(VABB)的日益普及主要歸功於其能夠透過單次穿刺高效採集多個連續組織樣本。該技術不僅顯著降低了漏診癌症和組織學低估的發生率,提高了診斷準確性,而且還能夠對纖維腺瘤等良性病變進行治療性切除。此外,經皮VABB的使用減少了更具侵入性的開放式切片檢查和切除手術的需求,從而降低了手術成本並縮短了住院時間。這些因素共同推動了全球VABB裝置市場的成長。
全球真空輔助乳房切片設備市場面臨的限制因素
全球真空輔助乳房切片設備市場受到該技術高昂的資本投入和營運成本的限制。這些設備需要真空產生器和專用切片檢查牙科手機等昂貴的組件,以及針頭、導管和定位標記等耗材的持續支出。因此,在許多醫療機構,真空輔助乳房切片檢查通常作為輔助切片檢查手段,僅用於細針穿刺切片檢查(FNA) 或粗切片檢查等領先技術效果不佳或影像學結果相互矛盾的情況。這一限制影響了真空輔助乳房切片在臨床實踐中的普及。
全球真空輔助乳房切片設備市場趨勢
受微創技術進步和人們對乳癌早期檢測日益成長的關注所驅動,全球真空輔助乳房切片市場正經歷顯著成長。廣泛的研究環境推動更精準診斷解決方案的創新,同時政府大力支持加強癌症研究基礎建設。這種有利的環境不僅促進了先進設備的研發,也鼓勵了醫療專業人員和研究人員之間的合作。隨著醫療保健系統越來越重視患者的舒適度和診斷的準確性,對真空輔助乳房切片活體組織切片設備的需求預計將持續成長,這反映了個人化醫療和早期療育策略的更廣泛趨勢。
Global Vacuum-Assisted Breast Biopsy Device Market size was valued at USD 906.84 Million in 2024 and is poised to grow from USD 1012.94 Million in 2025 to USD 2454.75 Million by 2033, growing at a CAGR of 11.7% during the forecast period (2026-2033).
The vacuum-assisted breast biopsy (VABB) device market is experiencing significant growth, propelled by the increasing prevalence of breast cancer, a major health concern for women globally. VABB offers superior response times compared to traditional diagnostic methods, which enhances its appeal. Its ability to extract substantial tissue samples with a single needle insertion allows for multiple specimens and contributes to more accurate diagnoses, thereby reducing the likelihood of missed cancer cases and histological underestimations. With breast cancer being a leading cause of mortality among women, heightened awareness and governmental initiatives for early detection are expected to further fuel the demand for VABB devices, solidifying their position as a preferred choice in modern breast cancer diagnostics.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vacuum-Assisted Breast Biopsy Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Vacuum-Assisted Breast Biopsy Device Market Segments Analysis
Global Vacuum-Assisted Breast Biopsy Device Market is segmented by Product, Type, Technique, Applications, End User and region. Based on Product, the market is segmented into Core Needle Biopsy Devices, Vacuum-assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Surgical Biopsy Devices and Others. Based on Type, the market is segmented into 9-12G, <9G and >12G. Based on Technique, the market is segmented into Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, MRI-Guided Biopsy and Others. Based on Applications, the market is segmented into Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy and Others. Based on End User, the market is segmented into Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Vacuum-Assisted Breast Biopsy Device Market
The increasing adoption of vacuum-assisted breast biopsy (VABB) devices over traditional biopsy techniques is primarily due to their ability to obtain multiple contiguous tissue samples efficiently with a single needle insertion. This method not only enhances diagnostic accuracy by significantly lowering cancer miss rates and histological underestimates but also allows for therapeutic removal of benign lesions like fibroadenomas. Additionally, utilizing percutaneous VABB can diminish the necessity for more invasive open surgical biopsies or excisions, leading to reduced operating costs and shorter hospital stays. Collectively, these factors are propelling the growth of the VABB device market globally.
Restraints in the Global Vacuum-Assisted Breast Biopsy Device Market
The Global Vacuum-Assisted Breast Biopsy Device market faces constraints due to the substantial capital investment and operational expenditures associated with the technology. These devices require expensive components such as vacuum generators and specialized biopsy hand-pieces, along with ongoing costs for consumables like needles, tubing, and localizing markers. Consequently, VABB is frequently employed as a secondary biopsy option in various medical facilities, often reserved for situations where earlier methods, such as fine needle aspiration (FNA) or core biopsies, have proven insufficient or yielded conflicting results with imaging studies. This limitation impacts the overall adoption of VABB in clinical practice.
Market Trends of the Global Vacuum-Assisted Breast Biopsy Device Market
The Global Vacuum-Assisted Breast Biopsy Device market is experiencing significant growth, fueled by advancements in minimally invasive technologies and a heightened focus on early breast cancer detection. An expansive research landscape has led to the innovation of more precise diagnostic solutions, garnering strong support from government initiatives aimed at enhancing cancer research infrastructures. This conducive environment not only facilitates the development of sophisticated devices but also encourages collaborative efforts among healthcare professionals and researchers. As healthcare systems increasingly prioritize patient comfort and accurate diagnostics, the demand for vacuum-assisted breast biopsy devices is poised for continued expansion, reflecting broader trends in personalized medicine and early intervention strategies.